Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AC-178335: new pure somatostatin antagonist that induces GH release in vivo

Feb. 25, 1999

Celtrix adds another patent to its SomatoKine portfolio

Feb. 25, 1999

Schein to introduce new product for management of hemodialysis patients with anemia

Feb. 24, 1999

Danish and Indian investigators disclose optically active nonsteroidal antiestrogens

Feb. 24, 1999

New obesity management drug approved in worldwide markets

Feb. 23, 1999

Raloxifene's effects on mood and cognitive function assessed

Feb. 23, 1999

Noven, Novartis and Vivelle Ventures to join in promoting osteoporosis nasal spray

Feb. 22, 1999

ERT gel available in Canada

Feb. 22, 1999

The relationship among ERT, cardiovascular disease and cancer

Feb. 22, 1999

Lilly cancels Targretin development program in diabetes with Ligand

Feb. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...